AstraZeneca (AZN) Health Care Sector

  • Latest quote

    6,159.00p (mid)

  • Current Change (%)

    1.23%

  • Price

    Bid: 6,170.00p

    Offer: 6,171.00p

  • Today

    High: 6,197.00p

    Low: 6,081.00p

  • This year

    High: 6,317.00p

    Low: 4,736.00p

  • Information

    Volume: 1,028,377

    Market Cap: £78034.53M



AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
AstraZeneca Full-Year and Q4 2018 Results 07:00 - February 14, 2019
US FDA grants Fasenra Orphan Drug Designation 07:00 - February 6, 2019
US FDA grants Breakthrough Therapy Designation 07:05 - February 5, 2019
EMA grants PRIME eligibility for MEDI8897 07:00 - February 5, 2019
Total Voting Rights 15:00 - February 1, 2019
Forxiga receives positive EU CHMP opinion 13:17 - February 1, 2019
Completion of divestment of US Synagis rights 14:00 - January 25, 2019
AstraZeneca announces organisational changes 13:00 - January 7, 2019
Total Voting Rights 15:00 - January 2, 2019
Bevespi Aerosphere approved in the EU for COPD 13:47 - December 20, 2018
Lynparza meets primary endpoint in SOLO-3 trial 07:05 - December 20, 2018
Phase III ROCKIES and OLYMPUS roxadustat trials 07:00 - December 20, 2018
FDA approves Lynparza as 1L maintenance therapy 18:31 - December 19, 2018
Roxadustat approved in China for the treatment of 09:09 - December 18, 2018
Update on the Phase III EAGLE trial of Imfinzi 07:00 - December 7, 2018

NOTE: This is based on 194 open tips for this company


Total Number of Share tips :

416

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today